U.S. Personal Products Stock News

Multiple securities class action lawsuits have been filed against Plug Power (NasdaqCM:PLUG), alleging misleading statements about its ability to secure and use a large Department of Energy loan and its hydrogen production expansion plans. At the same time, Plug Power completed the first hydrogen fill of a major pipeline in Rotterdam, marking progress in its European hydrogen infrastructure efforts. For investors tracking Plug Power at a share price of $1.84, these developments arrive after...

The U.S. Supreme Court’s decision to overturn Trump era tariffs has quickly filtered into markets. Under Armour (UAA) is among the stocks reacting as investors reassess potential cost pressures for manufacturers and retailers. See our latest analysis for Under Armour. Against the tariff news, Under Armour’s recent 30 day share price return of 20% and 90 day return of 69.33% point to building momentum. However, the 5 year total shareholder return of a 66.49% decline shows the longer term...

Seacoast Banking Corporation of Florida (SBCF) has drawn investor attention after recent share price moves. The stock has shown mixed short-term performance, while longer-term returns and current profit figures invite a closer look. See our latest analysis for Seacoast Banking Corporation of Florida. The recent 1-day share price return of a 4.77% decline at a last close of US$32.14 follows softer 7-day and 30-day share price returns. However, the 1-year total shareholder return of 18.17% and...

AECOM (NYSE:ACM) has announced a major global partnership with TomTom to support mobility and infrastructure planning. The collaboration focuses on using TomTom's traffic analytics to inform AECOM's transport and infrastructure solutions for public and private clients. The partnership is aimed at addressing global trends in urbanization, technology adoption, and sustainable infrastructure planning. AECOM, a global infrastructure consulting firm, works across transportation, water,...

Disc Medicine announced that the FDA issued a Complete Response Letter for its accelerated approval filing of bitopertin in erythropoietic protoporphyria, citing insufficient evidence that reductions in metal-free PPIX translate into improved sunlight tolerance despite positive biomarker data from the AURORA and BEACON trials. An interesting element for investors is that the FDA explicitly pointed to the ongoing APOLLO Phase III study as a potential path to traditional approval, while Disc...

Wondering if Equity LifeStyle Properties at around US$67.96 is offering fair value right now, or if the price is running ahead of reality? The stock has returned 0.2% over the past week, 6.2% over the last month, 13.7% year to date, 4.8% over 1 year, 8.0% over 3 years and 26.3% over 5 years. This provides a mix of short and longer term outcomes to weigh up. Recent news coverage has focused on Equity LifeStyle Properties as a large US listed real estate owner and operator, with investors...

Recent performance snapshot for Dime Community Bancshares (DCOM) Dime Community Bancshares (DCOM) has drawn attention after recent share price moves, with a 1 day return of a 4.38% decline and a 7 day return of a 7.01% decline, inviting a closer look at its fundamentals. See our latest analysis for Dime Community Bancshares. Beyond the recent pullback, Dime Community Bancshares has seen its 90 day share price return of 14.62% and 1 year total shareholder return of 11.50%. This suggests...

Axsome Therapeutics (AXSM) closed FY 2025 with Q4 revenue of US$196.0 million and a basic EPS loss of US$0.56, alongside a net income loss of US$28.6 million, keeping profitability firmly in focus for investors. The company has seen quarterly revenue move from US$118.8 million in Q4 2024 to US$196.0 million in Q4 2025, while basic EPS has shifted from a loss of US$1.54 to a loss of US$0.56 over the same period. This frames a story where top line scale is running ahead of bottom line progress...

Super Micro Computer (SMCI) recently lifted its full year revenue guidance to at least US$40b, well ahead of earlier consensus. Over 90% of this guidance is tied to AI platforms, and fresh insider share purchases reinforce management conviction. See our latest analysis for Super Micro Computer. Even with the raised revenue guidance and insider buying, the share price has been under pressure recently, with a 1 year total shareholder return of about a 41% decline following a very large 5 year...

Why Extra Space Storage Is Getting Attention Now Extra Space Storage (EXR) is drawing fresh interest after recent share moves, including a one-month return of about 6% and a past three-month gain of roughly 14%, prompting closer scrutiny of its fundamentals. See our latest analysis for Extra Space Storage. At around US$150.41, Extra Space Storage’s recent 7 day share price return of 2.77% and 90 day share price return of 13.63% suggest building momentum, even though the 1 year total...

Recent news around Nebius Group (NasdaqGS:NBIS) has centered on rising contracted power guidance, strong demand for its AI cloud services, ambitious 2026 revenue targets, and fresh momentum from major data center projects and customer wins. See our latest analysis for Nebius Group. The recent news flow around larger AI infrastructure contracts, raised contracted power guidance and the Tavily acquisition has coincided with building momentum, with a 30 day share price return of 6.47% and a 1...

In February 2026, Blue Planet announced that Lumen Technologies adopted its OSS-native AI Studio platform to deploy AI agents across multiple network domains, aiming to boost operational efficiency and customer experience while Lumen also expanded its enterprise portfolio with a Multi-Cloud Gateway and enhanced metro data-center connectivity for AI and hybrid workloads. These moves, combined with recent upgrades to Lumen’s credit ratings from all three major agencies, highlight a pivot...

Enpro Inc. reported past fourth-quarter 2025 sales of US$295.4 million and a net loss of US$32 million, issued 2026 revenue growth guidance of 8% to 12%, and signaled ongoing capacity for acquisitions under its Enpro 3.0 framework. The company is pairing a small quarterly dividend increase to US$0.32 per share with plans to pursue acquisitions that add technology, talent, and process expertise in its key growth areas. We’ll now examine how Enpro’s 2026 revenue guidance and acquisition...

If you are trying to figure out whether KKR is attractively priced or not, starting with a clear view of its current value story can help you frame your next move. KKR's share price recently closed at US$92.19, after a 9.4% decline over the last 7 days, a 24.0% decline over 30 days, a 28.5% decline year to date and a 29.3% decline over 1 year. Over longer periods, the 3 year and 5 year returns sit at 69.4% and 107.9% respectively. These moves have come alongside ongoing attention on global...

If you are wondering whether Performance Food Group's share price still offers value at around US$95.79, you are not alone. Many investors are asking the same question before making their next move. The stock has seen a 2.3% decline over the last 7 days, a 2.0% gain over 30 days, and is up 8.8% year to date, with a 15.6% return over 1 year, 65.2% over 3 years and 70.9% over 5 years. These figures may influence how you think about its risk and reward trade off. Recent company updates and...

In recent weeks, Hershey has been challenged by public claims from a Reese family member that Reese’s ingredients have been cheapened, which the company disputes, while also confronting softer unit sales, higher costs and pressure on operating margins. This clash between brand heritage concerns and evidence of less profitable incremental growth raises questions about how resilient Hershey’s product portfolio and pricing power really are. Next, we’ll examine how this ingredient controversy,...

What recent performance says about Novavax (NVAX) Novavax (NVAX) has quietly posted mixed share performance recently, with a 1 day return of 1.7%, a 7 day move of 7.6%, and gains over the past month and past 3 months. For longer term holders the picture is different, with a 1 year total return of 26.3%, around 8% over 3 years, and a much weaker 5 year outcome, which may influence how you frame risk and expectations. See our latest analysis for Novavax. At a share price of $9.36, Novavax has...

Allegiant Travel (ALGT) has drawn fresh attention after unveiling Flight #925, a themed Orlando to Knoxville route created with Dollywood Parks & Resorts. The offering pairs air travel with exclusive theme park, entertainment, and lodging perks. See our latest analysis for Allegiant Travel. The latest Flight #925 announcement comes after a stretch of strong momentum in Allegiant Travel’s share price, with a 43% 90 day share price return and 27.06% 1 year total shareholder return, contrasted...

If you are looking at Perrigo and wondering whether the recent share price reflects its true worth, this article will walk you through what the numbers are saying about value. The stock closed at US$14.55, with returns of 0.1% over 7 days, a 1.2% decline over 30 days, 4.8% year to date, and declines of 39.1% over 1 year, 54.5% over 3 years, and 58.8% over 5 years, which can change how investors see both risk and upside potential. Recent news coverage around Perrigo has focused on its...

KB Home (KBH) is back in focus after analysts flagged that upcoming results are expected to show weaker revenue and earnings versus last year, with recent estimate changes appearing to weigh more heavily on the stock. See our latest analysis for KB Home. At a share price of US$64.36, KB Home has seen a 9.01% 1 month share price return and a 12.77% year to date share price return. The 3 year total shareholder return of 90.48% contrasts with softer recent moves as analysts focus on potentially...

Recent share performance context for TransDigm Group Recent price moves in TransDigm Group (TDG) have drawn investor attention, with the stock showing mixed returns across different periods and prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for TransDigm Group. The recent pullback, with a 1 month share price return of an 8.67% decline and a year to date share price return of a 4.59% decline from US$1,296.15, contrasts with a 1 year total shareholder...

If you are wondering whether Okta's share price today reflects its true worth, you are not alone. This article will walk through how the current market view compares with several common valuation checks. Okta's share price closed at US$69.51, with returns of 20.3% decline over 7 days, 23.4% decline over 30 days, 16.9% decline year to date, 23.5% decline over 1 year, 3.0% decline over 3 years, and 74.2% decline over 5 years. These moves may have shifted how investors think about its risk and...

Wendy's (WEN) is back in focus after management paired cautious 2026 guidance, including flat global systemwide sales, with plans to close 5% to 6% of U.S. stores and rising pressure from activist Trian Partners. See our latest analysis for Wendy's. At a share price of US$7.77, Wendy's has seen a 3.9% one day share price decline and a 7.8% 90 day share price return decline, while the 1 year total shareholder return is down 48.3%. This suggests that recent activist headlines and cautious...

In February 2026, Bank of America Corporation completed and announced multiple senior unsecured bond offerings across maturities from 2027 to 2046 totaling several hundred million US dollars, while also unveiling a new Art Consulting service for wealth clients and deepening its data partnership with London Stock Exchange Group. Together with a US$25.00 billion commitment to private-credit deals, these moves highlight Bank of America’s push to broaden fee and interest income sources across...